FDA Import Refusal BJE-0117438-3/1/1 — Hospira, Inc.
The FDA refused shipment BJE-0117438-3/1/1 from Hospira, Inc. (United States) on April 20, 2011. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 20, 2011
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62OCP24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 27